Clinical Trial Update: Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 efficacy and safety trial of nonracemic methadone for diabetic peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Nonracemic methadone (methadone)

Snippet

Sponsor: MetaPharm, Inc. | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: COMPLETED